Who is the CEO of Hannah Joseph Hospital Ltd?
- Answer Field
-
Dr. Moses Joseph Arunkumar is the Chairman & Managing Director of Hannah Joseph Hospital Ltd.
Hannah Joseph Hospital Limited operates as a multi-specialty healthcare provider based in Madurai, focusing on delivering medical services across neurology, cardiology, psychiatry, and trauma care. The hospital functions from a dedicated campus equipped to support inpatient and surgical treatment, serving patients from the city and surrounding regions. Its core business is centred on providing secondary and tertiary healthcare services through specialised departments and trained medical professionals. The company’s market presence is primarily regional, with operations aligned to address the healthcare requirements of South Tamil Nadu through structured service delivery and facility-based care.
To apply for the Hannah Joseph Hospital IPO, investors need an active demat account and a bank account enabled for online applications. The IPO application can be submitted through the ASBA facility provided by banks or via supported online trading platforms that offer IPO application services. Applicants are required to select the IPO, enter the bid quantity as per the lot size mentioned in the offer document, and confirm the application. Once submitted, the application amount is blocked in the bank account until allotment is finalised. All application-related details are governed by the disclosures mentioned in the IPO prospectus.
For more details, visit the Hannah Joseph Hospital Limited IPO page.
Details | Information |
IPO Date | January 22, 2026 to January 27, 2026 |
Issue Size | 60,00,000 shares (agg. up to ₹42 Cr) |
Price Band | ₹67 to ₹70 per share |
Lot Size | 2,000 shares |
Listing At | BSE SME |
Market Maker | CapitalSquare Financial Services Private Limited |
Funding of capital expenditure for establishing Radiation Oncology Centre
General Corporate Purpose
Event | Date |
|---|---|
IPO Open Date | Thu, Jan 22, 2026 |
IPO Close Date | Tue, Jan 27, 2026 |
Tentative Allotment | Wed, Jan 28, 2026 |
Initiation of Refunds | Thu, Jan 29, 2026 |
Credit of Shares to Demat | Thu, Jan 29, 2026 |
Tentative Listing Date | Fri, Jan 30, 2026 |
Cut-off time for UPI mandate confirmation | 5 PM on Tue, Jan 27, 2026 |
₹67 to ₹70 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,80,000 |
Individual investors (Retail) (Max) | 2 | 4,000 | ₹2,80,000 |
S-HNI (Min) | 3 | 6,000 | ₹4,20,000 |
S-HNI (Max) | 7 | 14,000 | ₹9,80,000 |
B-HNI (Min) | 8 | 16,000 | ₹11,20,000 |
The Hannah Joseph Hospital Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Access your trading account using the broker's app or website.
Go to the IPO section to view active IPO listings.
Locate Hannah Joseph Hospital Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Specify the number of shares (lot size: 2,000 shares) within the price band of ₹67 to ₹70 per share.
Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Submit the application and monitor the allotment status to check if shares have been allocated to you.
The allocation of shares in the Hannah Joseph Hospital IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.
Investor Category | Shares Offered |
Market Maker Shares Offered | 3,00,000 (5.00%) |
QIB Shares Offered | 28,50,000 |
− QIB (Ex. Anchor) Shares Offered | - |
NII (HNI) Shares Offered | 8,55,000 (14.25%) |
Retail Shares Offered | 19,95,000 (33.25%) |
Total Shares Offered | 60,00,000 (100.00%) |
This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.
Total Assets: Grew from ₹92.14 crore in FY23 to ₹104.58 crore as of Sept 2025.
Total income: Stood at ₹42.75 crore in Sept 2025, as compared to ₹54.90 crore in FY23.
Profit After Tax (PAT): Stood at ₹5.12 crore for Sept 2025 as compared to ₹1.01 crore in FY23.
Net Worth: Recorded at ₹53.22 crore in Sept 2025 in comparison to ₹34.15 crore in FY23.
Reserves and surplus: Reached ₹40.36 crore in Sept 2025, as compared to ₹18.20 crore in FY23.
EBITDA: Stood at ₹11.65 crore in Sept 2025 in comparison to ₹16.38 crore in FY23.
The company has reported an expansion in its asset base, indicating continued investment in operational infrastructure and healthcare facilities.
Income levels reflect stable business activity, supported by ongoing patient services and specialised healthcare offerings.
Profitability has shown improvement over the period, supported by operational efficiencies and service expansion across departments.
The net worth position has strengthened, reflecting retained earnings and internal capital generation over recent years.
Reserves and surplus have increased, indicating a gradual build-up of internal financial resources for future requirements.
Operating performance has remained steady, with the company continuing to focus on optimising service delivery and cost management.
Overall, the hospital’s recent performance reflects a focus on sustaining operations while strengthening its financial position to support long-term healthcare service delivery.
The company’s operations are geographically concentrated in Madurai and surrounding regions, which may limit revenue diversification and expose performance to region-specific operational or regulatory challenges.
The healthcare business requires continuous investment in infrastructure, technology, and skilled professionals, and any delay or constraint in managing these requirements could affect service delivery and operations.
The planned establishment of a Radiation Oncology Centre may expand the hospital’s service offerings and support the development of additional specialised healthcare services.
Growing healthcare needs in South Tamil Nadu and nearby regions may support steady demand for secondary and tertiary care services, aligned with the company’s existing medical departments and infrastructure.
KPI | Sept 30, 2025 | Mar 31, 2025 |
ROE | 9.39% | 14.77% |
ROCE | 10.41% | 17.03% |
Debt/Equity | 0.55 | 0.65 |
RoNW | 9.62% | 14.74% |
PAT Margin | 12.03 | 9.30% |
EBITDA Margin | 27.38% | 26.47% |
Price to Book Value | 2.20 | 2.39 |
Registrar | Lead Manager(s) |
|---|---|
Bigshare Services Pvt.Ltd. | Capital Square Advisors Pvt.Ltd. |
Hannah Joseph Hospital Ltd. 134, Lake View Road K.K. Nagar, Madurai, Tamil Nadu, 625020
Phone: 9524729594
Email: cs@hannahjosephhospital.com
Website: https://hannahjosephhospital.com/
Hannah Joseph Hospital Limited operates as a regional healthcare provider offering multi-specialty medical services through its facility in Madurai. The company’s operations are focused on delivering secondary and tertiary care across key medical departments, supported by its existing infrastructure and workforce. The IPO objectives include funding specific capital expenditure and meeting general corporate requirements, as outlined in the offer documents.
The IPO application process is structured through standard online mechanisms using ASBA or supported trading platforms, subject to timelines and disclosures mentioned in the prospectus. Investors may refer to the offer document for details related to the company’s operations, financial position, risks, and issue structure before making an application decision.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Hannah Joseph Hospital IPO allotment status.
No result found
Dr. Moses Joseph Arunkumar is the Chairman & Managing Director of Hannah Joseph Hospital Ltd.
The Hannah Joseph Hospital IPO is scheduled to open for subscription on January 22, 2026, and will close on January 27, 2026. These dates are subject to the timelines mentioned in the offer documents and exchange notifications.
Hannah Joseph Hospital Limited operates as a multi-specialty healthcare provider offering secondary and tertiary care services in areas such as neurology, cardiology, psychiatry, and trauma care. Its business model is based on facility-based healthcare delivery through a dedicated hospital campus in Madurai. Long-term sustainability depends on operational efficiency, regulatory compliance, and the ability to manage healthcare infrastructure and professional resources.
The IPO comprises 60,00,000 equity shares, aggregating up to ₹42 crore, as disclosed in the issue details. The final issue size is subject to the price band and subscription outcomes.
The pre-apply facility allows investors to place an IPO application before the official opening date. The application is submitted in advance, but the payment mandate is activated only when the IPO opens for subscription, subject to confirmation within the specified timeline.
The lot size for the IPO is 2,000 shares. Retail investors are required to apply for a minimum of two lots, which translates to 4,000 shares, as per the application structure mentioned in the offer details.
The tentative allotment date for the IPO is January 28, 2026, as per the disclosed timeline. The final allotment is subject to exchange approval and completion of the allotment process.
Bigshare Services Pvt. Ltd. has been appointed as the registrar to the Hannah Joseph Hospital IPO. The registrar is responsible for handling allotment, refunds, and investor-related queries.
There are no publicly stated governance issues or red flags highlighted. Investors may review the offer documents, including sections on management, board composition, and risk factors, for detailed and verified disclosures.
The IPO application can be made online through ASBA-enabled bank accounts or supported trading platforms. Investors need to select the IPO, enter the bid quantity as per the lot size, provide their UPI ID, and confirm the mandate within the stipulated timeline mentioned in the offer documents.
Yes, a demat account is mandatory to apply for the IPO, as the shares are allotted only in electronic form and credited directly to the investor’s demat account upon allotment.
Investors can check the allotment status on the registrar’s website or through the exchange platform once the allotment is finalised. If shares are allotted, they will be credited to the demat account, and if not, the blocked amount will be released as per the process timeline
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading